DBV Technologies - Aktienkurs

Aktienkurs
21.70
Täglich Wechseln
0.63 2.99%
Monatlich
3.88%
Jährlich
409.39%
Q1 Prognose
20.36



Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 24.08 -0.25 -1.03% 18.68% 2026-02-20
Alnylam Pharmaceuticals 341.09 1.72 0.51% 35.89% 2026-02-20
Amarin 15.89 0.17 1.08% 33.75% 2026-02-20
BioCryst Pharmaceuticals 7.43 -0.05 -0.67% -20.87% 2026-02-20
BioMarin Pharmaceutical 63.88 0.46 0.73% -7.06% 2026-02-20
DBV Technologies 21.70 0.63 2.99% 409.39% 2026-02-20
Esperion Therapeutics 3.49 -0.04 -0.99% 91.48% 2026-02-20
Galectin Therapeutics 2.95 0.02 0.67% 97.96% 2026-02-20
Halozyme Therapeutics 72.01 -0.03 -0.04% 24.69% 2026-02-20
Incyte 101.87 0.14 0.14% 41.27% 2026-02-20

Preis Tag Jahr Datum
USND 22814 131.21 0.58% 16.85% 2026-02-20